Is ALBO or DIVO a better dividend investment in 2026?

ALBO currently yields 4.53% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: DIVO offers higher current income.

What is the dividend yield difference between ALBO and DIVO?

ALBO has a forward dividend yield of 4.53% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 1.96 percentage points.

Home › Compare › ALBO vs DIVO

ALBO vs DIVO: Dividend Comparison 2026

ALBO yields 4.53% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DIVO wins by $3.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

ALBO

● Live price

4.53%

Share price

$44.15

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$26.9K

Annual income

$605.56

Full ALBO calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — ALBO vs DIVO

📍 DIVO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ALBO	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ALBO + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ALBO pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALBO

Annual income on $10K today (after 15% tax)

$385.05/yr

After 10yr DRIP, annual income (after tax)

$514.73/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, DIVO beats the other by $319.70/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALBO + DIVO for your $10,000?

ALBO: 50%DIVO: 50%

100% DIVO50/50100% ALBO

Portfolio after 10yr

$28.8K

Annual income

$793.62/yr

Blended yield

2.75%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ALBO right now

ALBO

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$44.00

-0.3% upside vs current

Range: $42.00 — $48.00

Altman Z

0.5

Piotroski

4/9

DIVO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALBO buys

DIVO buys

No recent congressional trades found for ALBO or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricALBODIVO

Forward yield	4.53%	6.49% ✓
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$26.9K	$30.7K ✓
Annual income after 10y	$605.56	$981.68 ✓
Total dividends collected	$5.3K	$8.2K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ALBO vs DIVO ($10,000, DRIP)

Year	ALBO Portfolio	ALBO Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$11,153	$453.00	$11,349	$649.42	$196.00 → DIVO
2	$12,406	$472.18	$12,833	$688.83	$427.00 → DIVO
3	$13,765	$490.86	$14,459	$727.90	$694.00 → DIVO
4	$15,238	$509.01	$16,238	$766.49	$1.0K → DIVO
5	$16,831	$526.60	$18,179	$804.47	$1.3K → DIVO
6	$18,553	$543.61	$20,293	$841.71	$1.7K → DIVO
7	$20,411	$560.02	$22,591	$878.14	$2.2K → DIVO
8	$22,416	$575.82	$25,087	$913.65	$2.7K → DIVO
9	$24,576	$591.00	$27,791	$948.18	$3.2K → DIVO
10	$26,902	$605.56	$30,718	$981.68	$3.8K → DIVO

ALBO vs DIVO: Complete Analysis 2026

ALBO — Stock

Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as well as in Phase III clinical trial for treating biliary atresia, alagille syndrome, and rare and life-threatening disorder to children; and Elobixibat for the treatment of chronic constipation and other functional diseases. It also engages in the developing of A3907, which is in Phase I clinical trial for the treatment of adult liver diseases; and A2342, a preclinical candidate to treat adult viral and liver diseases. The company has a license agreement with EA Pharma Co., Ltd. for the development and commercialization of elobixibat. Albireo Pharma, Inc. is headquartered in Boston, Massachusetts.

Full ALBO Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this ALBO vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALBO vs SCHD ALBO vs JEPI ALBO vs O ALBO vs KO ALBO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.